JP2019535310A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019535310A5 JP2019535310A5 JP2019545223A JP2019545223A JP2019535310A5 JP 2019535310 A5 JP2019535310 A5 JP 2019535310A5 JP 2019545223 A JP2019545223 A JP 2019545223A JP 2019545223 A JP2019545223 A JP 2019545223A JP 2019535310 A5 JP2019535310 A5 JP 2019535310A5
- Authority
- JP
- Japan
- Prior art keywords
- terminal
- seq
- amino acid
- acid sequence
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2016-0149090 | 2016-11-09 | ||
| KR20160149090 | 2016-11-09 | ||
| PCT/KR2017/012651 WO2018088813A2 (ko) | 2016-11-09 | 2017-11-09 | Nkx3.2 단편 및 이를 유효성분으로 포함하는 약학 조성물 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020183392A Division JP7055455B2 (ja) | 2016-11-09 | 2020-11-02 | Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019535310A JP2019535310A (ja) | 2019-12-12 |
| JP2019535310A5 true JP2019535310A5 (enExample) | 2020-12-17 |
| JP6991593B2 JP6991593B2 (ja) | 2022-01-12 |
Family
ID=62110655
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545223A Active JP6991593B2 (ja) | 2016-11-09 | 2017-11-09 | Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 |
| JP2020183392A Active JP7055455B2 (ja) | 2016-11-09 | 2020-11-02 | Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020183392A Active JP7055455B2 (ja) | 2016-11-09 | 2020-11-02 | Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11235025B2 (enExample) |
| EP (2) | EP3539978B1 (enExample) |
| JP (2) | JP6991593B2 (enExample) |
| KR (4) | KR102049987B1 (enExample) |
| CN (2) | CN110036023B (enExample) |
| AU (2) | AU2017358282C1 (enExample) |
| CA (1) | CA3042186C (enExample) |
| ES (2) | ES2987020T3 (enExample) |
| WO (1) | WO2018088813A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3060947B1 (fr) * | 2016-12-28 | 2025-12-26 | Ynsect | Procede de traitement d'insectes comprenant la separation des cuticules de la partie molle des insectes puis la separation de la partie molle en trois fractions |
| CA3112915A1 (en) * | 2018-10-19 | 2020-04-23 | Icm Co., Ltd. | Pharmaceutical composition for treating retinal diseases, comprising nkx3.2 and fragment thereof as active ingredients |
| KR102336515B1 (ko) * | 2018-10-25 | 2021-12-07 | 애니젠 주식회사 | 부포린 유도체 및 이의 용도 |
| CN112409454B (zh) * | 2020-11-04 | 2022-07-05 | 青岛农业大学 | 一种法氏囊七肽及其制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| BR112012004777A2 (pt) * | 2009-09-03 | 2019-09-24 | Genentech Inc | métodos para tratar diagnósticar e monitorar artrite reumatoide |
| WO2011093647A2 (en) * | 2010-01-26 | 2011-08-04 | Industry-Academic Cooperation Foundation, Yonsei University | Genes implicated in osteoarthritis and use thereof |
| KR101150900B1 (ko) * | 2010-01-26 | 2012-05-30 | 연세대학교 산학협력단 | 퇴행성 관절염 치료 조성물 |
| KR101150990B1 (ko) | 2010-06-19 | 2012-06-13 | 김유정 | 슬롯리스 고정자를 갖는 브러시리스 직류 모터 |
| WO2012097057A2 (en) * | 2011-01-11 | 2012-07-19 | Tufts University | Methods, compositions and kits for modulating trans-differentiation of muscle satellite cells |
| UY35368A (es) * | 2013-03-08 | 2014-10-31 | Irm Llc | Péptidos y composiciones para el tratamiento de daño articular |
| CA2915296A1 (en) * | 2013-06-11 | 2015-02-26 | Portage Pharmaceuticals Ltd. | Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides |
| KR102044530B1 (ko) | 2017-04-21 | 2019-11-14 | 아이씨엠 주식회사 | Nkx3.2 및 이의 단편을 유효성분으로 포함하는 망막질환 치료용 약학적 조성물 |
-
2017
- 2017-11-09 EP EP17868981.6A patent/EP3539978B1/en active Active
- 2017-11-09 WO PCT/KR2017/012651 patent/WO2018088813A2/ko not_active Ceased
- 2017-11-09 EP EP21154441.6A patent/EP3835311B1/en active Active
- 2017-11-09 CN CN201780069569.5A patent/CN110036023B/zh active Active
- 2017-11-09 CA CA3042186A patent/CA3042186C/en active Active
- 2017-11-09 ES ES21154441T patent/ES2987020T3/es active Active
- 2017-11-09 KR KR1020170148493A patent/KR102049987B1/ko active Active
- 2017-11-09 JP JP2019545223A patent/JP6991593B2/ja active Active
- 2017-11-09 ES ES17868981T patent/ES3009014T3/es active Active
- 2017-11-09 CN CN202211029784.1A patent/CN115925865A/zh active Pending
- 2017-11-09 AU AU2017358282A patent/AU2017358282C1/en active Active
- 2017-11-09 KR KR1020170148509A patent/KR102049978B1/ko active Active
- 2017-11-09 US US16/348,540 patent/US11235025B2/en active Active
-
2019
- 2019-11-05 KR KR1020190140236A patent/KR102340761B1/ko active Active
-
2020
- 2020-02-28 US US16/805,370 patent/US11154590B2/en active Active
- 2020-07-24 AU AU2020207879A patent/AU2020207879B2/en active Active
- 2020-11-02 JP JP2020183392A patent/JP7055455B2/ja active Active
- 2020-11-02 KR KR1020200144613A patent/KR102342171B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018518457A5 (enExample) | ||
| JP2021520203A5 (enExample) | ||
| JP2016500519A5 (enExample) | ||
| JP2014512171A5 (enExample) | ||
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| RU2018136611A (ru) | Генная терапия для лечения гемофилии a | |
| JP2010516252A5 (enExample) | ||
| JP2019525744A5 (enExample) | ||
| JP2015512876A5 (enExample) | ||
| FI4206216T3 (fi) | Adenoassosioituneen viruksen kapsidimuunnoksia ja menetelmiä niiden käyttämiseksi | |
| JP2019513794A5 (enExample) | ||
| JP2021512126A5 (enExample) | ||
| JP2009525052A5 (enExample) | ||
| JP2016538885A5 (enExample) | ||
| JP2020510428A5 (enExample) | ||
| RU2010100913A (ru) | Слитые белки rage | |
| JP2020519292A5 (enExample) | ||
| HRP20161305T1 (hr) | Liječenje mikrobnih infekcija | |
| JP2020512822A5 (enExample) | ||
| JP2017523239A5 (enExample) | ||
| JP2018501791A5 (enExample) | ||
| JP2014529399A5 (enExample) | ||
| JP2023539247A5 (enExample) | ||
| JP2020533968A5 (enExample) | ||
| JP2022500353A (ja) | Ｉｇｆ−１−暗号化ｄｎａ作製物及びｈｇｆ−暗号化ｄｎａ作製物を用いた神経病症治療 |